This research, led by UNC School of Medicine scientists Laura Kincer, Sarah Joseph,and Ron Swanstrom with international collaborators, shows that in addition to HIV’s ability to lay dormant in the blood/lymphoid system, the virus may also lay dormant in the central nervous system, delineating another challenge in creating a cure.
A new North Carolina study called VISION is now underway to answer some of the biggest questions about COVID-19. The study plans to enroll 7,500 COVID-positive individuals to understand the different factors that impact individual risk for key clinical outcomes, including recovery from acute illness, symptom rebound, re-infection and long COVID.
This project’s goal is to validate a new technology for detecting inferior-quality chemotherapy products at the point of use in four countries; Ethiopia, Malawi, Kenya and Cameroon. These countries do not conduct post-market surveillance testing on chemotherapy products so there is no good evidence on what percentage of the chemo drugs are adequate quality.
The academy recognizes individuals who have demonstrated outstanding professional achievement and commitment to service throughout their careers.